Soft Tissue Sarcoma — Trials

Soft Tissue Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

1,383 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 338
Recruiting: 188
Ph III recruiting: 14
Growth YoY: −16.5%
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (195)

clinicaltrialsPublishedShowing 51–53 of 53 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04165330	Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors	active not recruiting	Phase 1 / Phase 2	56	Sarcoma Oncology Research Center, LLCOTHER	1	Feb 24, 2025	clinicaltrials
NCT04733183	Efficacy and Safety of L19TNF in Previously Treated Patients with Advanced Stage or Metastatic Soft-tissue Sarcoma(FLASH)	active not recruiting	Phase 2	98	Philogen S.p.A.INDUSTRY	5	Jan 27, 2025